Analytical Data
-
Gene name
STK19
- Application
-
Alternative Names
STK19; G11; RP1; Serine/threonine-protein kinase 19; EC 2.7.11.1; Protein G11; Protein RP1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P49842
-
Expression Region
1-368 aa
-
AA Sequence
MQKWFSAFDD AIIQRQWRAN PSRGGGGVSF TKEVDTNVAT GAPPRRQRVP GRACPWREPI RGRRGARPGG GDAGGTPGET VRHCSAPEDP IFRFSSLHSY PFPGTIKSRD MSWKRHHLIP ETFGVKRRRK RGPVESDPLR GEPGSARAAV SELMQLFPRG LFEDALPPIV LRSQVYSLVP DRTVADRQLK ELQEQGEIRI VQLGFDLDAH GIIFTEDYRT RVCDCVLKAC DGRPYAGAVQ KFLASVLPAC GDLSFQQDQM TQTFGFRDSE ITHLVNAGVL TVRDAGSWWL AVPGAGRFIK YFVKGRQAVL SMVRKAKYRE LLLSELLGRR APVVVRLGLT YHVHDLIGAQ LVDCISTTSG TLLRLPET
-
Molecular Weight
28.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
STK19 is a member of the Serine/Threonine Kinase (STK) family, which plays crucial roles in various cellular processes, including cell growth, differentiation, and apoptosis. Recent research has shown that STK19 is potentially involved in several pathological conditions, including cancer and neurological disorders, making it a target of interest for therapeutic interventions. The exploration of STK19 recombinant protein has gained traction due to its potential implications in signal transduction pathways that are often dysregulated in disease states. By producing STK19 as a recombinant protein, researchers aim to investigate its functional properties, structural characteristics, and interactions with other signaling molecules. This endeavor not only enhances our understanding of STK19’s biological roles but also paves the way for the development of novel drugs targeting STK19-related pathways. Moreover, understanding the post-translational modifications and regulatory mechanisms of STK19 at the molecular level could provide insights into its function and its role in diseases, thus potentially contributing to new strategies for diagnosis and treatment. Therefore, further studies on the recombinant expression and characterization of STK19 are vital for elucidating its biological significance and therapeutic potential in various contexts.
